220 related articles for article (PubMed ID: 8246138)
41. Additive effects of losartan and enalapril on blood pressure and plasma active renin.
Azizi M; Guyene TT; Chatellier G; Wargon M; Ménard J
Hypertension; 1997 Feb; 29(2):634-40. PubMed ID: 9040450
[TBL] [Abstract][Full Text] [Related]
42. Effect of sodium chloride, enalapril, and losartan on the development of polycystic kidney disease in Han:SPRD rats.
Keith DS; Torres VE; Johnson CM; Holley KE
Am J Kidney Dis; 1994 Sep; 24(3):491-8. PubMed ID: 8079975
[TBL] [Abstract][Full Text] [Related]
43. Vasopeptidase inhibitor restores the balance of vasoactive hormones in progressive nephropathy.
Benigni A; Zoja C; Zatelli C; Corna D; Longaretti L; Rottoli D; Maggioni P; Todeschini M; Noris M; Remuzzi G
Kidney Int; 2004 Nov; 66(5):1959-65. PubMed ID: 15496167
[TBL] [Abstract][Full Text] [Related]
44. Effect of ANG II receptor antagonist on albuminuria and renal function in passive Heymann nephritis.
Hutchinson FN; Webster SK
Am J Physiol; 1992 Aug; 263(2 Pt 2):F311-8. PubMed ID: 1510124
[TBL] [Abstract][Full Text] [Related]
45. Prevention of thromboxane A2 receptor-mediated pulmonary hypertension by a nonpeptide angiotensin II type 1 receptor antagonist.
Bertolino F; Valentin JP; Maffre M; Jover B; Bessac AM; John GW
J Pharmacol Exp Ther; 1994 Feb; 268(2):747-52. PubMed ID: 8113986
[TBL] [Abstract][Full Text] [Related]
46. Is the antiproteinuric effect of ACE inhibition mediated by interference in the renin-angiotensin system?
Gansevoort RT; de Zeeuw D; de Jong PE
Kidney Int; 1994 Mar; 45(3):861-7. PubMed ID: 8196289
[TBL] [Abstract][Full Text] [Related]
47. Effects of chronic treatment with angiotensin converting enzyme inhibitor or an angiotensin receptor antagonist in two-kidney, one-clip hypertensive rats.
Imamura A; Mackenzie HS; Lacy ER; Hutchison FN; Fitzgibbon WR; Ploth DW
Kidney Int; 1995 May; 47(5):1394-402. PubMed ID: 7637269
[TBL] [Abstract][Full Text] [Related]
48. Renal responses to angiotensin receptor antagonist and angiotensin-converting enzyme inhibitor in partially nephrectomized spontaneously hypertensive rats.
Okada H; Suzuki H; Kanno Y; Ikenaga H; Saruta T
J Cardiovasc Pharmacol; 1995 Oct; 26(4):564-9. PubMed ID: 8569216
[TBL] [Abstract][Full Text] [Related]
49. Angiotensin blockade reverses hypertension during long-term nitric oxide synthase inhibition.
Pollock DM; Polakowski JS; Divish BJ; Opgenorth TJ
Hypertension; 1993 May; 21(5):660-6. PubMed ID: 7684026
[TBL] [Abstract][Full Text] [Related]
50. Effects of an angiotensin II receptor antagonist on the progression of renal failure in hyperlipidemic Imai rats.
Sakemi T; Baba N
Nephron; 1993; 65(3):426-32. PubMed ID: 8289994
[TBL] [Abstract][Full Text] [Related]
51. The angiotensin II receptor antagonist losartan reduces blood pressure but not renal injury in obese Zucker rats.
Crary GS; Swan SK; O'Donnell MP; Kasiske BL; Katz SA; Keane WF
J Am Soc Nephrol; 1995 Oct; 6(4):1295-9. PubMed ID: 8589300
[TBL] [Abstract][Full Text] [Related]
52. Enalapril in hypertension with renal artery stenosis: long-term follow-up and effects on renal function.
Tillman DM; Malatino LS; Cumming AM; Hodsman GP; Leckie BJ; Lever AF; Morton JJ; Webb DJ; Robertson JI
J Hypertens Suppl; 1984 Dec; 2(2):S93-100. PubMed ID: 6100883
[TBL] [Abstract][Full Text] [Related]
53. Renal protective effects of chronic exercise and antihypertensive therapy in hypertensive rats with chronic renal failure.
Kohzuki M; Kamimoto M; Wu XM; Xu HL; Kawamura T; Mori N; Nagasaka M; Kurosawa H; Minami N; Kanazawa M; Saito T; Yoshida K
J Hypertens; 2001 Oct; 19(10):1877-82. PubMed ID: 11593110
[TBL] [Abstract][Full Text] [Related]
54. Effect of angiotensin II blockade on dietary protein-induced renal growth.
Smith LJ; Rosenberg ME; Hostetter TH
Am J Kidney Dis; 1993 Jul; 22(1):120-7. PubMed ID: 8322774
[TBL] [Abstract][Full Text] [Related]
55. TCV 116 prevents progressive renal injury in rats with extensive renal mass ablation.
Mackenzie HS; Troy JL; Rennke HG; Brenner BM
J Hypertens Suppl; 1994 Nov; 12(9):S11-6. PubMed ID: 7884578
[TBL] [Abstract][Full Text] [Related]
56. The effects of angiotensin II receptor blockade with losartan on systemic blood pressure and renal and extrarenal prostaglandin synthesis in women with essential hypertension.
Smith MC; Barrows S; Meibohm A; Shahinfar S; Simpson RL; Weigel K; Dunn MJ
Am J Hypertens; 1995 Dec; 8(12 Pt 1):1177-83. PubMed ID: 8998251
[TBL] [Abstract][Full Text] [Related]
57. Prophylaxis of experimental bone marrow transplant nephropathy.
Cohen EP; Moulder JE; Fish BL; Hill P
J Lab Clin Med; 1994 Sep; 124(3):371-80. PubMed ID: 8083580
[TBL] [Abstract][Full Text] [Related]
58. Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism.
Mazzali M; Kanellis J; Han L; Feng L; Xia YY; Chen Q; Kang DH; Gordon KL; Watanabe S; Nakagawa T; Lan HY; Johnson RJ
Am J Physiol Renal Physiol; 2002 Jun; 282(6):F991-7. PubMed ID: 11997315
[TBL] [Abstract][Full Text] [Related]
59. Role of aldosterone in the remnant kidney model in the rat.
Greene EL; Kren S; Hostetter TH
J Clin Invest; 1996 Aug; 98(4):1063-8. PubMed ID: 8770880
[TBL] [Abstract][Full Text] [Related]
60. Renin-angiotensin system and minoxidil-induced cardiac hypertrophy in rats.
Ruzicka M; Leenen FH
Am J Physiol; 1993 Nov; 265(5 Pt 2):H1551-6. PubMed ID: 8238566
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
